Skorpios Trust Akero Therapeutics, Inc. Transaction History

Skorpios Trust

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$36.89 - $56.88 $60.9 Million - $93.9 Million	-1,650,000 Reduced 50.43%	1,621,829 $75.7 Million
Q4 2022 Feb 07, 2023	SELL	$33.44 - $54.8 $54.7 Million - $89.7 Million	-1,636,000 Reduced 33.33%	3,271,829 $179 Million
Q4 2021 Jan 27, 2022	BUY	$19.87 - $26.24 $97.5 Million - $129 Million	4,907,829 New	4,907,829 $104 Million

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.52B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Skorpios Trust, based on Form 13F filings with the SEC.

Stay updated on Skorpios Trust with notifications on news.